116171 ⎘
Hydrolases acting on ester bonds (3.1) Carboxylic ester hydrolases (3.1.1)
Sub-classes:FUMONISIN ENZYMATIC DEGRADATION
#2SYSTEMS AND METHODS FOR EPICARDIAL TISSUE DISTENSION SOLUTIONS
#3Baking With Thermostable AMG Glucosidase Variants (EC 3.2.1.3) And Low Or No Added Emulsifier
#4NOVEL LIPASE
#5Methods for Producing Circular Deoxyribonucleic Acids
#6BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS
#7INSECT-DERIVED, ENZYME-MODIFIED LIPID COMPOSITION
#8METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#9LIPASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
#10NOVEL ESTERASES AND USES THEREOF
#11DETERGENT COMPOSITIONS
#12METHOD FOR PREPARING BETA-CAROTENE FROM PEPPER PIGMENT AND PRODUCT THEREOF
#13METHODS AND COMPOSITIONS FOR GENOME EDITING
#14METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#15METHODS, COMPOSITIONS, AND DEVICES FOR SUPPLYING DIETARY FATTY ACID NEEDS
#16METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS
#17COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND AN INSECTICIDE
#18COMPOSITIONS COMPRISING RECOMBINANT BACILLUS CELLS AND AN INSECTICIDE
#19PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND
#20CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#21IDEONELLA SAKAIENSIS PET-HYDROLASE VARIANT WITH INCREASED THERMOSTABILITY
#22POLYMER DEGRADING ENZYMES
#23METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#24VARIANT ENZYMES AND USES THEREOF
#25CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#26RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1
#27SOLUBILIZATION OF MSW WITH BLEND ENZYMES
#28Methods, compositions, and devices for supplying dietary fatty acid needs
#29Methods and compositions for genome editing in non-dividing cells
#30Hydrolase and method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid using same
#31Method for producing fatty alcohol esters of hydroxycarboxylic acids
#32Esterases and uses thereof
#33Enzyme complex for decomposing polyethylene terephthalate and manufacturing method thereof
#34MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS
#35GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES
#36METHOD FOR ENZYMATICALLY PRODUCING MAYTANSINOL
#37Methods, compositions, and devices for supplying dietary fatty acid needs
#38Methods, compositions, and devices for supplying dietary fatty acid needs
#39Methods, compositions, and devices for supplying dietary fatty acid needs
#40Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#41Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#42Detergent compositions
#43Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#44Compositions comprising recombinant cells and an insecticide
#45Decellularization of Plant Cell Culture Materials for Tissue Engineering and Drug Delivery
#46Solubilization of MSW with blend enzymes
#47LEADER SEQUENCE FOR YEAST
#48Brewing method
#49CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#50Triamine solidification using diacids
#51Solubilization of MSW with blend enzymes
#52METHOD FOR IMPROVING ANTICANCER AGENT EFFICACY
#53ENGINEERED MICROORGANISMS FOR THE DECONSTRUCTION OF POLYMERS
#54NOVEL ESTERASES AND USES THEREOF
#55Methods, compositions, and devices for supplying dietary fatty acid needs
#56ENGINEERED MICROORGANISMS FOR THE DECONSTRUCTION OF POLYMERS
#57Bioconversion of levulinic acid in genetically engineered hosts
#58METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#59CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#60Hydrolase and method for producing (1S,2S)-1-alkoxycarbonyl-2-vinylcyclopropane carboxylic acid using same
#61Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#62having antimicrobial effect on and
#63Glycosylated mono(2-hydroxyethyl) terephthalic acid and glycosylated bis(2-hydroxyethyl) terephthalic acid
#64COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES
#65Methods and compositions for diagnosing and treating diseases
#66TRANSGENIC STRAIN FOR PRODUCING SUCCINATE AND METHOD FOR PRODUCING SUCCINATE
#67Esterases and uses thereof
#68Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody
#69Decellularization of plant cell culture materials for tissue engineering and drug delivery
#70Increasing the content of long chain fatty acids in seed oil
#71Triamine solidification using diacids
#72Detergent compositions
#73CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#74Esterases and uses thereof
#75Methods and compositions for genome editing in non-dividing cells
#76Method of treatment of schizophreniform disorder
#77Polypeptides with lipase activity and polynucleotides encoding same for cleaning
#78Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#79SUBSTANTIALLY NON-RACEMIC KETONE ESTER OF BETA HYDROXYBUTYRATE AND PRODUCTION PROCESS THEREOF
#80Factors for the production and accumulation of polyunsaturated fatty acids (PUFAs) derived from PUFA synthases
#81Bioconversion of levulinic acid in genetically engineered hosts
#82Lipase variants and polynucleotides encoding same
#83Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment
#84Polypeptides with lipase activity and polynucleotides encoding same
#85Sulfite compositions
#86Device and method of producing ultra-low sulfur biodiesel
#87Methods, compositions, and devices for supplying dietary fatty acid needs
#88Methods, compositions, and devices for supplying dietary fatty acid needs
#89Compositions and methods for modulating ABHD2 activity
#90MOLECULAR MACHINES
#91Amphoteric ester sulfonates
#92Polypeptides with lipase activity and polynucleotides encoding same
#93Antimicrobial traditional Chinese medicine composition, and preparation method and use thereof
#94BIOSYNTHETIC PATHWAYS AND METHODS
#95Methods and compositions for the treatment of symptoms of prion diseases
#96Brewing method
#97Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
#98Methods, compositions, and devices for supplying dietary fatty acid needs
#99Lipase variants and polynucleotides encoding same
#100Lipase variants and polynucleotides encoding same
#101Solubilization of MSW with blend enzymes
#102Compositions comprising recombinant cells and an insecticide
#103Methods, compositions, and devices for supplying dietary fatty acid needs
#104Methods, compositions, and devices for supplying dietary fatty acid needs
#105Solubilization of MSW with blend enzymes
#106Lactone hydrolase and method of degrading alpha-zearalenol using the same
#107Method of treatment of schizophreniform disorder
#108PROCESS AND DEVICE FOR PRODUCING FUEL HYDROCARBON OIL
#109Triamine solidification using diacids
#110Engineered biocatalysts useful for carbapenem synthesis
#111Methods, compositions, and devices for supplying dietary fatty acid needs
#112SYNTHETIC CATALYTIC MIMICS OF ESTERASES, LIPASES OR DESATURASES
#113Polypeptides with lipase activity and polynucleotides encoding same
#114Red-shifted luciferins and methods of using same
#115NOVEL LUNG CANCER BIOMARKER (LIPH)
#116Factors for the production and accumulation of polyunsaturated fatty acids (PUFAS) derived from PUFA synthases
#117Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#118Polypeptide for hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof as well as a polypeptide containing an additive, use of same as well as a process
#119Polypeptides with lipase activity and polynucleotides encoding same for cleaning
#120Use of Enzyme Particles in Water-Soluble Films
#121Polypeptides having phospholipase A activity and polynucleotides encoding same
#122Lipase variants and polynucleotides encoding same
#123CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#124Vulcanisaetal phosphotriesterase-like lactonases (PLL) having enhanced properties and the uses thereof
#125Compositions and kits for treating pruritus and methods of using the same
#126Enzyme formulation for use as food supplement
#127Amphoteric ester sulfonates
#128CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#129Increasing the content of long chain fatty acids in seed oil
#130Detergent compositions
#131Stabilized humicola lanuginosa lipase variants in water-soluble films
#132Method of treating mucopolysaccharidosis type I or II
#133Heavy metal resistant esterase
#134Engineered biocatalysts useful for carbapenem synthesis
#135Biosynthetic pathways and methods
#136Methods and compositions for the treatment of symptoms of prion diseases
#137Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#138Methods, compositions, and devices for supplying dietary fatty acid needs
#139Mycotoxin-reducing composition
#140Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
#141Method of treatment of schizophreniform disorder
#142Polypeptides having alpha-glucuronidase activity and polynucleotides encoding same
#143Method of enzyme inactivation
#144Lipase variants and polynucleotides encoding same
#145Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
#146Process for the enzymatic synthesis of (7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or esters thereof, and application in the synthesis of ivabradine and salts thereof
#147SERUM AND TISSUE BIOMARKERS OF HUMAN HCC
#148Expression and application of recombinant FAEES in algae as a novel method to produce biodiesel in vivo
#149Perhydrolase variant providing improved specific activity
#150Compositions and methods for treatment or prevention of infections and for the eradication or reduction of on surfaces
#151Methods and compositions for diagnosing and treating diseases
#152MYCOTOXIN-REDUCING COMPOSITION
#153Method of using lipid acyltransferase
#154Method for producing ultra-heat treatment milk
#155Esterases and their use
#156METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#157Fungal lypolytic and amylase enzyme composition and methods using the same
#158Fungal lipolytic enzymes, nucleic acids encoding, and uses thereof
#159Delayed release pancreatin compositions
#160Method of using lipid acyltransferase
#161Method of using lipid acyltransferase
#162Method of using lipid acyltransferase
#163Method
#164Dual roles of pepper esterase as a biocontrol agent
#165Method of preparing zearalenone hydrolase